INJECTIONS of aliphatic nitrogen mustards (Boyland, Clegg, Koner, Rhoden and Warwick, 1948 ; Stock, 1950) have proved of therapeutic value, but sometimes produce chnically undesirable side effects (Nabarro, 1950) . The tris(2-chloroethyl)amine (HN3), for instance, seemed very promising (Wilkinson and Fletcher, 1947 ;  Jiminez Diaz, Merchante, Perianes, Lopez and Puig, 195 1), but its use has been discouraged by the great risk of thrombosis at the site of injection (Rhoads, 1946 ; Nabarro, 1950) . Clinical reports on the oral activitv of V an aromatic nitrogen mustard, NN-di(2-chloroethyl)P naphthylamine, R 4 '8 (Haddow, Kon and Ross, 1948) and of triethylene melamine, T.E.M. (Karnofsky, (Jager, Wintrobe, Ginzler and Gordon, 1943) . It seemed of interest, therefore, to see if aliphatic nitrogen mustards have an oral activity against tumour-growth comparable to that of R 48 or T.E.M. Tests with these two compounds and with three aliphatic nitrogen mustards, bis(2-chloroethAamine (nor HN2), bis(2-chloroethyl)methylamine (HN2) and HN3, against transplanted tumour are described in this paper. (Craigie, 1949) and preserved at-70'C. (Craigie, 1949 (Craigie, , 1952 (Boyland, Cleg, Koller, Rhoden and Warwick, 1948; Haddow, Kon and Ross, 1948 (a) 1'est animal-s fed ad libitum.-The three aliphatic nitrogen mustards when administered orall also retarded tumour-growth. The maximum tolerated oral dose was about twice the maximum tolerated intraperitoneal dose. Using these doses, both oral and parenteral treatment produced similar effects against the Walker tumour (Table 11 ). The oral activity seeme 'd to be influenced by the distribution of the total dose ; the weight ratio between control and HN2-treated tumours became more significant when the total dose was divided over 7 instead of over IO da-ily doses. Boyland, Cleg, Koller, Rhoden and '"Tarwick (1948) found that the parenteral activitv of nitrogen mustards increased when the total dose was given as a single injection. When given in a single oral do the effect of HN3 was negligible, whereas the activity of HN2 and nor HN2 seemed to be increased to a certain extent. The oral activity of nor HN2 seemed at least equal to that of HN2, and more pronounced than that of HN3, but even the highest weight ratios between control-tumours and those treated with the ahphatic compounds were only about one-quarter of the ratio recorded after treatment with R 48 (Table II) . The other aromatic nitrogen mustard tested, NN-bis(2 chloroethyl)p-phenylene diamine hydrochloride, when given as a single oral dose of 4 mg. per kg. was inactive. Larger doses were active but toxic.
T.E.M., though strikingly suppressive after intraperitoneal injection, retarded the growth of the Walker tumour to a negligible extent when given orally. When the maximum tolerated dose of 4 mg. per kg. rat was divided over 10 days, no activity was seen. When the same amount was given in a single dose, tumourgrowth was shghtly but probably significantly retarded. Influence of the age of the test animals.
All the tests described above were carried out on young rats. Some furth'er tests were performed with the adult group to find whether the permeability of the gastro-intestinal mucosa decreases with maturation. Some of the results varied with the age-grou'p. After oral treatment with HN3 the weight ratios between control and treated tumours were greater in the young rats. In adult rats 2 mg.
per kg. retarded tumour-growth slightly but significantly; 2-8 and 3-2 mg. per kg. produced an effect similar to that produced in the young animals by 2 and 2-8 mg. per kg. respectively. It is doubtful whether these differences were due to a greater permeability of the gastro-intestinal mucosa in the young rats, for after oral treatment with HN2 the ratios were greater in the adult rats, but not in the young rats (Table IV) 
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In the case of haloarvlalk amines with little or no tumour-inhibitory activity, it was found that the replacement of chlorine by the more reactive bromine produced active compounds (Haddow, Kon and Ross, 1948) . Bromine substitution in HN2 and HN3, however, did not increase the activity against the Walker tumour ; in fact, given in the doses in which the chlorine compounds were active the two bromine compounds showed no inhibitory activity whatever. Toxicity of the nitrogen mustard8and triethylene melamine in tumour-bearer8.
Given orally, R 48 was tolerated in a dose about 36 and 50 ti'mes the maximum tolerated doses of HN2 and HN3 respectively. The maximum tolerated oral dose of nor HN2 was about 10 times larger than that of HN2 and 14 times larger than that of HN3 (Table 11 ). The therapeutic ratio of HN2 and HN3, whether the drugs were given intraperitoneally or orally, seemed as low as 2, or even lower. The addition of adrenocortical extract (Kucharik and Telbisz, 1945) or urethane (Anslow, Karnofsky, Jager and.Smith,. 1947 )-has been-rep-orted-to reduce the toxicity of mustards. An attempt at reducing the toxicity of HN3 in this way was unsuccessful. The experiment is described here because it has been suggested that urethane potentiates the effect of nitrogen mustards clinically. Three groups of adult bearers of Walker tumour received HN3 orally in a daily dose of 0-4 mg. per kg. rat for 8 days. One group received in addition intraperitoneal injections of 25 mg. of urethane daily, a dose of urethane whichper8e is known to be inactive against the Walker tumour. Another group received unstandardized adrenocortical extract (Eucortone) intraperitoneally, I ml. (corresponding to 75 mg. of fresh gland) being given daily at the same time as the HN3. The toxicity of HN3 was not reduced by these collateral treatments; some animals died, and the survivors lost more weight than those which had received HN3 alone. The weight ratio between control tumours and those treated with HN3 + urethane (22) was greater than that between controls and those treated with HN3 alone (14), but the difference was statistically not quite significant (P<0-05>0-02) and does not prove a potentiating effect.
DISCUSSION.
The inbibition of growth of the Walker tumour produced by oral adminstration of aliphatic nitrogen mustards was comparable to that produced by administration of these reagents parenterally. Nor HN2 appeared to be at least as active as and at the same time less toxic than HN2 or HN3. Oral treatment with triethylene molamine, on the other hand, produced no significant inhibition of tumour-growth unless given to fasting rats, but to these a dose which was tolerated by fed rats proved toxic. This result is not at variance with those of previous workers. Hendry, Homer, Rose and Walpole (I 95 1) found triethylene melamine orally active against the Walker tumour, but the figures published by these authors show that the oral doses were I 0 to 20 times greater than those which they had found markedly active after injection. Paterson and Boland (1951) found the haematological response to oral doses less predictable than to parenteral treatment. Clinical trials by Karnofsky, Burchonal, Armistead, Southam, Benstein, Craver and Rhoads (1951) showed that the drug reacts readily with organic material in the stomach and is therefore almost inactivated unless given during fast.
As 
